Patents by Inventor David John Scanlon

David John Scanlon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • In vivo assays for modulators of sterol biosynthesis
    Patent number: 6828092
    Abstract: A method for the identification of agents which modulate sterol biosynthesis which method comprises contacting a test compound with a host cell comprising a DNA sequence which controls expression of a yeast acetoacetyl CoA thiolase gene operably linked to a reporter system such that modulation of sterol biosynthesis in the host cell leads to a detectable change in cell phenotype, and determining whether any such detectable change has occurred.
    Type: Grant
    Filed: January 12, 1998
    Date of Patent: December 7, 2004
    Assignee: Astrazeneca UK Limited
    Inventors: Graham Keith Dixon, Peter Michael Broad, David John Scanlon